>
Switch to:

Turning Point Therapeutics Debt-to-Revenue

: N/A As of Dec. 2020
View and export this data going back to 2019. Start your Free Trial

Debt-to-Revenue measures a company's ability to pay off its debt.

Turning Point Therapeutics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $1.40 Mil. Turning Point Therapeutics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $2.42 Mil. Turning Point Therapeutics's annualized Revenue for the quarter that ended in Dec. 2020 was $0.00 Mil.


Turning Point Therapeutics Debt-to-Revenue Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
Debt-to-Revenue - - - 0.15

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Debt-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.04 -

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Turning Point Therapeutics Debt-to-Revenue Distribution

* The bar in red indicates where Turning Point Therapeutics's Debt-to-Revenue falls into.



Turning Point Therapeutics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Turning Point Therapeutics's Debt-to-Revenue for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.396 + 2.423) / 25
=0.15

Turning Point Therapeutics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2020 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1.396 + 2.423) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2020) Revenue data.


Turning Point Therapeutics Debt-to-Revenue Related Terms


Turning Point Therapeutics Debt-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)